Tissue-Specific Response to Interstitial Angiotensin II in Humans

Abstract—Angiotensin II is synthesized locally in various tissues; however, the role of interstitial angiotensin II in the regulation of regional metabolism and tissue perfusion is not clear. We characterized the effect of interstially applied angiotensin II in skeletal muscle and subcutaneous adipose tissue of young, normal-weight, healthy subjects by using the microdialysis technique. Furthermore, we tested the hypothesis that the effect of interstitial angiotensin II is modulated by nitric oxide. Tissues were perfused with 0.01, 0.1, and 1 &mgr;mol/L angiotensin II in the presence of the l- or d-isomer of NG-nitro-arginine-methyl ester (L- or D-NAME), the effective and noneffective isomer, respectively, for blocking nitric oxide synthase. Dialysate ethanol, glycerol, glucose, lactate, and pyruvate concentrations were measured to assess changes in blood flow (ethanol dilution technique), lipolysis, and glycolysis, respectively. Baseline blood flow and dialysate concentrations of the metabolites were similar with L- and D-NAME in both tissues. Blood flow and dialysate glucose and lactate did not change significantly in both tissues during perfusion with angiotensin II. Dialysate glycerol dose-dependently increased in adipose tissue (P <0.0438) but decreased in muscle (P <0.007). In muscle, dialysate pyruvate increased (P <0.0002), whereas lactate/pyruvate ratio decreased (P <0.001), both dose-dependently. All effects were similar with L- and D-NAME and could be reversed by nitroprusside. We conclude that in contrast to the profound hemodynamic effect of intravascular angiotensin II, interstitial angiotensin II has a minimal acute effect on blood flow in both tissues. However, interstitial angiotensin II modulates lipid and carbohydrate metabolism in a tissue specific fashion. Thus, the physiology of interstitial angiotensin II cannot be predicted from intravascular studies.

[1]  J. Jordan,et al.  In Vivo Response to α1‐Adrenoreceptor Stimulation in Human White Adipose Tissue , 2002 .

[2]  L. Navar,et al.  Renal Interstitial Fluid Concentrations of Angiotensins I and II in Anesthetized Rats , 2002, Hypertension.

[3]  J. Jordan,et al.  In vivo response to alpha(1)-adrenoreceptor stimulation in human white adipose tissue. , 2002, Obesity research.

[4]  A. Dominiczak,et al.  Angiotensin receptors: signaling, vascular pathophysiology, and interactions with ceramide. , 2001, American journal of physiology. Heart and circulatory physiology.

[5]  S. Klaus,et al.  Metabolic and hemodynamic response of adipose tissue to angiotensin II. , 2001, Obesity research.

[6]  N. Christensen,et al.  Interaction between β-Adrenergic Receptor Stimulation and Nitric Oxide Release on Tissue Perfusion and Metabolism1 , 2001 .

[7]  H. Brunner Experimental and clinical evidence that angiotensin II is an independent risk factor for cardiovascular disease. , 2001, The American journal of cardiology.

[8]  N. Christensen,et al.  Interaction between beta-adrenergic receptor stimulation and nitric oxide release on tissue perfusion and metabolism. , 2001, The Journal of clinical endocrinology and metabolism.

[9]  Arya M. Sharma,et al.  The renin-angiotensin system and natriuretic peptides in obesity-associated hypertension , 2001, Journal of Molecular Medicine.

[10]  Y. Giudicelli,et al.  Endogenous nitric oxide is implicated in the regulation of lipolysis through antioxidant-related effect. , 2000, American journal of physiology. Cell physiology.

[11]  L. Cavallini,et al.  Oral N-acetyl-cysteome increases the production of anti HIV chemokines in peripheral blood mononuclear cells. , 2000, Life sciences.

[12]  S. Engeli,et al.  Physiology and pathophysiology of the adipose tissue renin-angiotensin system. , 2000, Hypertension.

[13]  Shokei Kim,et al.  Molecular and cellular mechanisms of angiotensin II-mediated cardiovascular and renal diseases. , 2000, Pharmacological reviews.

[14]  H. Eichler,et al.  Paracrine effects of angiotensin-converting-enzyme- and angiotensin-II-receptor- inhibition on transcapillary glucose transport in humans. , 2000, Life sciences.

[15]  C. González,et al.  Nitric oxide and the renin-angiotensin system. Is there a physiological interplay between the systems? , 1999, Journal of hypertension.

[16]  Y. Giudicelli,et al.  Modulation of White Adipose Tissue Lipolysis by Nitric Oxide* , 1998, The Journal of Biological Chemistry.

[17]  P. Lönnroth Microdialysis in Adipose Tissue and Skeletal Muscle , 1997, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

[18]  B. H. Jones,et al.  Angiotensin II increases lipogenesis in 3T3-L1 and human adipose cells. , 1997, Endocrinology.

[19]  P. Arner,et al.  Application of in situ microdialysis to measure metabolic and vascular responses in adipose tissue. , 1996, Trends in pharmacological sciences.

[20]  J. Bolinder,et al.  Evaluation of the microdialysis ethanol technique for monitoring of subcutaneous adipose tissue blood flow in humans. , 1996, International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity.

[21]  U. Ungerstedt,et al.  Interstitial glucose and lactate balance in human skeletal muscle and adipose tissue studied by microdialysis. , 1993, The Journal of physiology.

[22]  M Lafontan,et al.  Fat cell adrenergic receptors and the control of white and brown fat cell function. , 1993, Journal of lipid research.

[23]  P. Timmermans,et al.  Angiotensin II receptors and angiotensin II receptor antagonists. , 1993, Pharmacological reviews.

[24]  U. Ungerstedt,et al.  The ethanol technique of monitoring local blood flow changes in rat skeletal muscle: implications for microdialysis. , 1992, Acta physiologica Scandinavica.

[25]  A. Astrup,et al.  Noradrenaline release in skeletal muscle and in adipose tissue studied by microdialysis. , 1991, Clinical science.

[26]  U. Ungerstedt,et al.  A comparison between three methods for estimation of extracellular concentrations of exogenous and endogenous compounds by microdialysis. , 1991, Journal of pharmacological methods.

[27]  L. Dwoskin,et al.  Presynaptic modulation of neurotransmitter release by endogenous angiotensin II in brown adipose tissue. , 1991, Journal of neural transmission. Supplementum.

[28]  D. Campbell,et al.  Simultaneous radioimmunoassay of six angiotensin peptides in arterial and venous plasma of man. , 1990, Journal of hypertension.

[29]  D. Campbell,et al.  Circulating and tissue angiotensin systems. , 1987, The Journal of clinical investigation.

[30]  B. Waeber,et al.  Specific measurement of angiotensin metabolites and in vitro generated angiotensin II in plasma. , 1986, Hypertension.

[31]  W. Campbell,et al.  Modulation of adrenergic transmission by angiotensins in the perfused rat mesentery. , 1979, The American journal of physiology.

[32]  P. Arner,et al.  Metabolism of mono- and diacylglycerols in subcutaneous adipose tissue of obese and normal-weight subjects. , 2009, Acta medica Scandinavica.

[33]  R. Bonnichsen Ethanol: Determination with Alcohol Dehydrogenase and DPN , 1965 .

[34]  Hans Ulrich Bergmeyer,et al.  Methods of Enzymatic Analysis , 2019 .